Causes of death in patients with rheumatoid arthritis: Comparison with siblings and matched osteoarthritis controls

Journal of Rheumatology

Volumn 34, Issue 8, 2007, Pages 1695-1698

  Kumar, Namita ^a   Marshall, Nicola J ^a   Hammal, Donna M ^b   Pearce, Mark S ^b   Parker, Louise ^b   Furniss, Stephen S ^a   Platt, Philip N ^a   Walker, David J ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Cardiovascular disease; Deaths; Osteoarthritis; Rheumatoid arthritis; Siblings

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; HIP OSTEOARTHRITIS; HUMAN; ISCHEMIC HEART DISEASE; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIBLING; SURVIVAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CAUSE OF DEATH; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NEOPLASMS; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; SIBLINGS;

EID: 34547953776     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Pincus T, Brooks RH, Callahan LF. Prediction of long term mortality in patients with rheumatoid arthritis. Ann Intern Med 1994;120:26-34.
2. Jacobsson LT, Knowler WC, Pillemer S, et al. Rheumatoid arthritis and mortality. A longitudinal study in Pima Indians. Arthritis Rheum 1993;36:1045-53.
3. Wallberg-Jonsson S, Cederfelt M, Rantapaa Dahlqvist S. Hemostatic factors and cardiovascular disease in active rheumatoid arthritis: an 8 year followup study. J Rheumatol 2000;27:71-5.
4. Kitas G, Banks MJ, Bacon PA. Cardiac involvement in rheumatoid disease. Clin Med 2001;1:18-21.
5. Smith SC, Greenland P, Grundy SM. AHA Conference Proceedings. Prevention Conference V. Beyond secondary prevention: Identifying the high risk patient for primary prevention. Circulation 2000;101:111-6.
6. McEntegart A, Capell HA, Creran D, Rumley A, Woodward M, Lowe GD. Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology Oxford 2001;40:640-4.
7. Hippisley-Cox J, Coupland C. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal-anti- inflammatory drugs: population based nested case control analysis. BMJ 2005;330:1366-9.
8. Furstenberger G, Krieg P, Muller-Decker K, Habenicht AJ. What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis? Int J Cancer 2006;119:2247-54.
9. Deighton CM, Roberts DF, Walker DJ. Effect of disease severity on rheumatoid arthritis concordance in same sexed siblings. Ann Rheum Dis 1992;51:943-5.
10. Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958;9:175-6.
11. Lakkireddy DR, Gowda MS, Murray CW, Basarakodu KR, Vacek JL. Death certificate completion: how well are physicians trained and are cardiovascular causes overstated? Am J Med 2004;117:492-8.
12. Messite J, Stellman SD. Accuracy of death certificate completion: the need for formalized physician training. JAMA 1996;275:794-6.
13. Bjornadal L, Brandt L, Klareskog L, Askling J. Impact of parental history on patients' cardiovascular mortality in rheumatoid arthritis. Ann Rheum Dis 2006;65:741-5.
14. Watson DJ, Rhodes T, Guess HA. All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis or no arthritis in the UK General Practice Research Database. J Rheumatol 2003;30:1196-202.
15. Arber N, DuBois RN. Nonsteroidal anti-inflammatory drugs and prevention of colorectal cancer. Curr Gastroenterol Rep 1999;1:441-8.
16. Corley DA, Kerlikowske K, Verma R, Buffler P. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterol 2003;124:47-56.
17. Zaridze D, Borisova E, Maximovitch D, Chkhikvadze V. Aspirin protects against gastric cancer: results of a case-control study from Moscow, Russia. Int J Cancer 1999;82:473-6.
18. Schreinemachers DM, Everson RB. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 1994;5:138-46.
19. Ratnasinghe LD, Graubard BI, Kahle L, Tangrea JA, Taylor PR, Hawk E. Aspirin use and mortality from cancer in a prospective cohort study. Anticancer Res 2004;24:3177-84.
20. Castelao JE, Yuan JM, Gago-Dominguez M, Yu MC, Ross RK. Non-steroidal anti-inflammatory drugs and bladder cancer prevention. Br J Cancer 2000;82:1364-9.
21. Farragher TM, Bruce IN. Cardiovascular risk in inflammatory rheumatic diseases: loose ends and common threads. J Rheumatol 2006;33:2105-7.
22. Akram MR, Handler CE, Williams M, et al. Angiographically proven coronary artery disease in scleroderma. Rheumatology Oxford 2006;45:1395-8.